Literature DB >> 2947901

The mechanism of Ca2+ regulation of vascular smooth muscle thin filaments by caldesmon and calmodulin.

C W Smith, K Pritchard, S B Marston.   

Abstract

The interactions of vascular smooth muscle caldesmon with actin, tropomyosin, and calmodulin were determined under conditions in which the four proteins can form reconstituted Ca2+-sensitive smooth muscle thin filaments. Caldesmon bound to actin in a complex fashion with high affinity sites (K = 10(7) M-1) saturating at a stoichiometry of 1 per 28 actins, and lower affinity sites at 1 per 7 actins. The affinity of binding was increased in the presence of tropomyosin, and this could be attributed to a direct interaction between caldesmon and tropomyosin which was demonstrated using caldesmon cross-linked to Sepharose. In the presence of tropomyosin, occupancy of the high affinity sites was associated with inhibition of actin-activated myosin MgATPase activity. Caldesmon was found to bind to calmodulin in the presence of Ca2+, with an affinity of 10(6) M-1. The binding of Ca2+ X calmodulin to caldesmon was associated with the neutralization of inhibition of actin-tropomyosin. Ca2+ X calmodulin binding reduced but did not abolish the binding of caldesmon to actin-tropomyosin. From this data we have proposed a model for smooth muscle thin filaments in which Ca2+ regulates activity by converting the inhibited actin-tropomyosin-caldesmon complex to the active complexes, actin-tropomyosin-caldesmon-calmodulin X Ca2+ and actin-tropomyosin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2947901

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Sarcomeric binding pattern of exogenously added intact caldesmon and its C-terminal 20-kDa fragment in skinned fibers of skeletal muscle.

Authors:  S M Frisbie; M C Reedy; L C Yu; B Brenner; J M Chalovich; T Kraft
Journal:  J Muscle Res Cell Motil       Date:  1999-04       Impact factor: 2.698

2.  A novel Ca2+ binding protein associated with caldesmon in Ca2+-regulated smooth muscle thin filaments: evidence for a structurally altered form of calmodulin.

Authors:  G Notarianni; N Gusev; D Lafitte; T J Hill; H S Cooper; P J Derrick; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

Review 3.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

4.  Acrylodan-labeled smooth muscle tropomyosin reports differences in the effects of troponin and caldesmon in the transition from the active state to the inactive state.

Authors:  Joseph M Chalovich; Evan Lutz; Tamatha Baxley; Mechthild M Schroeter
Journal:  Biochemistry       Date:  2011-06-14       Impact factor: 3.162

5.  Stoichiometry and stability of caldesmon in native thin filaments from sheep aorta smooth muscle.

Authors:  S Marston
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

6.  A mosaic multiple-binding model for the binding of caldesmon and myosin subfragment-1 to actin.

Authors:  Y D Chen; J M Chalovich
Journal:  Biophys J       Date:  1992-10       Impact factor: 4.033

Review 7.  Calponin (CaP) as a latch-bridge protein--a new concept in regulation of contractility in smooth muscles.

Authors:  Pawel T Szymanski
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

Review 8.  Vascular smooth muscle contractile elements. Cellular regulation.

Authors:  J T Stull; P J Gallagher; B P Herring; K E Kamm
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

Review 9.  What is latch? New ideas about tonic contraction in smooth muscle.

Authors:  S B Marston
Journal:  J Muscle Res Cell Motil       Date:  1989-04       Impact factor: 2.698

10.  Filamin and gelsolin influence Ca(2+)-sensitivity of smooth muscle thin filaments.

Authors:  N B Gusev; K Pritchard; J L Hodgkinson; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.